Title	Publication Date	Language	Citations
Pharmacogenomics: The promise of personalized medicine	2000/03/01	English	97
Comparison of the gravimetric, phenol red, and 14C-PEG-3350 methods to determine water absorption in the rat single-pass intestinal perfusion model	2001/09/01	English	94
Maturation and growth of renal function: Dosing renally cleared drugs in children	2000/03/01	English	89
Mechanisms of aggregate formation and carbohydrate excipient stabilization of lyophilized humanized monoclonal antibody formulations	2003/06/01	English	86
Lipid-based supramolecular systems for topical application: A preformulatory study	2003/12/01	English	85
Visualization of the lipid barrier and measurement of lipid pathlength in human stratum corneum	2001/06/01	English	83
Pharmacodynamic modeling of chemotherapeutic effects: Application of a transit compartment model to characterize methotrexate effects in vitro	2002/12/01	English	81
Physiologically based pharmacokinetics in Drug Development and Regulatory Science: A workshop report (Georgetown University, Washington, DC, May 29–30, 2002)	2004/03/01	English	79
A novel in vitro release method for submicron-sized dispersed systems	1999/09/01	English	77
A photo-crosslinked poly(vinyl alcohol) hydrogel growth factor release vehicle for wound healing applications	2003/12/01	English	76
Assessing the cost-effectiveness of pharmacogenomics	2000/09/01	English	75
Spatial expression patterns of peptide transporters in the human and rat gastrointestinal tracts, Caco-2 In Vitro cell culture model, and multiple human tissues	2001/03/01	English	74
A short-term (accelerated release) approach to evaluate peptide release from PLGA depot formulations	1999/09/01	English	73
β-cyclodextrin complexes of celecoxib: Molecular-modeling, characterization, and dissolution studies	2004/03/01	English	69
Pharmacokinetics of paclitaxel-containing liposomes in rats	2003/12/01	English	68
Role of MRP4 and MRP5 in biology and chemotherapy	2002/09/01	English	63
Pharmacokinetic/pharmacodynamic integration in drug development and dosage-regimen optimization for veterinary medicine	2002/12/01	English	58
Maltodextrin-based proniosomes	2001/01/05	English	56
Receptor-targeted gene delivery viafolate-conjugated polyethylenimine	1999/12/01	English	55
Comparisons of pKa and log P values of some carboxylic and phosphonic acids: Synthesis and measurement	2001/06/01	English	55
Permeability classification of representative fluoroquinolones by a cell culture method	2004/06/01	English	54
Cellular uptake and concentrations of tamoxifen upon administration in poly(ε-caprolactone) nanoparticles	2003/03/01	English	53
Which concentration of the inhibitor should be used to predict in vivo drug interactions from in vitro data?	2002/12/01	English	52
Chitosan and sodium alginate—Based bioadhesive vaginal tablets	2002/12/01	English	50
Allometric scaling of xenobiotic clearance: Uncertainty versus universality	2001/12/01	English	49
Light-scattering investigations on dilute nonionic oil-in-water microemulsions	2000/06/01	English	47
Time-and concentration-dependent penetration of doxorubicin in prostate tumors	2001/06/01	English	47
Design and synthesis of the CB1 selective cannabinoid antagonist AM281: A potential human SPECT ligand	1999/06/01	English	47
Comparative studies to determine the selective inhibitors for P-glycoprotein and cytochrome P 4503A4	1999/12/01	English	47
Assuring quality and performance of sustained and controlled release parenterals: EUFEPS workshop report	2004/03/01	English	46